BEST UNLIMITED TURBO LONG CERTIFICATE - MEDTRONIC Share Price

Certificat

Q668S

DE000SU63BL8

Real-time Euronext Paris 08:13:46 15/05/2024 pm IST
4.235 EUR +0.24% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - MEDTRONIC
Current month+13.73%
1 month+13.73%
Date Price Change
15/24/15 4.235 +0.24%
14/24/14 4.225 +0.96%
13/24/13 4.185 +5.02%
10/24/10 3.985 +1.01%
09/24/09 3.945 +2.33%

Real-time Euronext Paris

Last update May 15, 2024 at 08:13 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
Q668S
ISINDE000SU63BL8
Date issued 17/01/2024
Strike 61.45 $
Maturity Unlimited
Parity 5 : 1
Emission price 5.03
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.4
Lowest since issue 3.38
Spread 0.01
Spread %0.23%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
84.3 USD
Average target price
94.77 USD
Spread / Average Target
+12.43%
Consensus
  1. Stock Market
  2. Certificates
  3. Q668S Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW